Biomarker Changes After a Course of Psilocybin-Enhanced Psychotherapy for the Treatment of Methamphetamine Use Disorder
Abstract
This study will assess several biomarker changes from baseline to after a 6-week course of psilocybin-assisted psychotherapy versus treatment-as-usual for veterans with methamphetamine use disorder admitted to a residential treatment facility on the Portland VA campus. Specific biomarker outcomes include: inflammatory markers (C-reactive protein, IL-1β, IL-6, TNF-a, IL-8, IL-10, CCL2, and CCL3), diurnal cortisol variation, and resting heart rate variability.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.